Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Revisão |
| 言語: | 英語 |
| 出版事項: |
2020
|
| オンライン･アクセス: | https://doi.org/10.1080/14737159.2020.1768849 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|